Radiotherapy for unresectable hepatic malignancies

被引：23

作者：

Ben-Josef, E ^{[1
]}

Lawrence, TS ^{[1
]}

机构：

[1] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA

来源：

SEMINARS IN RADIATION ONCOLOGY | 2005年 / 15卷 / 04期

关键词：

hepatic malignancies; radiotherapy; stereotactic radiotherapy; TACE (transcatheter arterial chemoembolization); radiopharmaceuticals;

D O I：

10.1016/j.semradonc.2005.04.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The management of hepatic malignancies, primary or metastatic, is an increasingly common problem in clinical practice. Unfortunately, most patients present with unresectable disease for which there is no universally accepted standard therapy. Radiotherapy is gaining importance in the management of these tumors and in this article we will review the advancements made in this field recently. Increased understanding of the relationship between radiation dose and volume and the risk of radiation-induced liver disease (RILD) has allowed delivery of high-dose focal liver radiation with encouraging results. A recent US phase II trial suggests a radiation dose-dependent improvement in survival when compared to historical controls. Others have reported favorable experience with moderate-dose external-beam radiotherapy, stereotactic hypofractionated radiotherapy, and radiopharmaceuticals. © 2005 Elsevier Inc. All rights reserved.

引用

页码：273 / 278

页数：6

共 34 条

[1]

*AM CANC SOC, CANC FACTS FIG 2003

[2]

ANDREWS JC, 1994, J NUCL MED, V35, P1637

[3] Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing [J].

Balter, JM ;

TenHaken, RK ;

Lawrence, TS ;

Lam, KL ;

Robertson, JM .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (01) :167-174

[4] Daily targeting of intrahepatic tumors for radiotherapy [J].

Balter, JM ;

Brock, KK ;

Litzenberg, DW ;

McShan, DL ;

Lawrence, TS ;

Ten Haken, R ;

McGinn, CJ ;

Lam, KL ;

Dawson, LA .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (01) :266-271

[5] STEREOTAXIC HIGH-DOSE FRACTION RADIATION-THERAPY OF EXTRACRANIAL TUMORS USING AN ACCELERATOR - CLINICAL-EXPERIENCE OF THE FIRST 31 PATIENTS [J].

BLOMGREN, H ;

LAX, I ;

NASLUND, I ;

SVANSTROM, R .

ACTA ONCOLOGICA, 1995, 34 (06) :861-870

[6]

BREEDIS C, 1954, AM J PATHOL, V30, P969

[7] Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer [J].

Cunningham, D ;

Pyrhönen, S ;

James, RD ;

Punt, CJA ;

Hickish, TF ;

Heikkila, R ;

Johannesen, TB ;

Starkhammar, H ;

Topham, CA ;

Awad, L ;

Jacques, C ;

Herait, P .

LANCET, 1998, 352 (9138) :1413-1418

[8] Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies [J].

Dawson, LA ;

McGinn, CJ ;

Normolle, D ;

Ten Haken, RK ;

Walker, S ;

Ensminger, W ;

Lawrence, TS .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (11) :2210-2218

[9]

Dawson LA, 2002, INT J RADIAT ONCOL, V53, P810, DOI 10.1016/S0360-3016(02)02846-8

[10] The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update [J].

El-Serag, H ;

Davila, JA ;

Petersen, NJ ;

McGlynn, KA .

ANNALS OF INTERNAL MEDICINE, 2003, 139 (10) :817-823

← 1 2 3 4 →